Ampersand Biosciences Receives SBIR Grant 2022

Ampersand Biosciences has been awarded the SBIR Grant for 2022 for immunologic analysis of non-mammalian and underrepresented mammalian models such as hamster.

Species: Hamster
Focus: Severe infectious diseases, Influenza, SARS-CoV-2